Table 1.
Demographic and clinico-pathological characteristics of cases
| Characteristics | Mean | Range |
|---|---|---|
| Age of Diagnosis (Years) | ||
| 56.36 years | 29–85 years | |
| Tumor Size | 58.0 mm | 2.0–120.0 mm |
| Frequency | Percentage | |
| Breast Cancer Subtypes | ||
| HER2 | 8 | 11.4 |
| Luminal A | 21 | 30 |
| Luminal B | 15 | 21.4 |
| Luminal B (Ki-67 ≥ 14%) | 9 | 12.9 |
| Luminal B HER2+ | 6 | 8.6 |
| Triple Negative | 26 | 37.1 |
| ER Status | ||
| Positive | 35 | 50 |
| Negative | 35 | 50 |
| PR Status | ||
| Positive | 32 | 45.7 |
| Negative | 38 | 54.3 |
| HER2 Status | ||
| Amplified | 13 | 18.6 |
| Not Amplified | 57 | 81.4 |
| Stage | ||
| I | 15 | 23.4 |
| II | 29 | 41.4 |
| III | 16 | 22.9 |
| IV | 4 | 5.7 |
| Grade | ||
| Grade I: Well differentiated | 1 | 1.4 |
| Grade II: Moderately differentiated | 15 | 21.4 |
| Grade III: Poorly differentiated | 52 | 74.3 |